Faculty Profiles - MATSUSHITA, Tadashi

Papers - MATSUSHITA, Tadashi

Division display 121 - 140 of about 231 ／ All the affair displays >>

The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A

Male, C; Königs, C; Dey, S; Matsushita, T; Millner, AH; Zak, M; Young, G; Kenet, G

BLOOD ADVANCES Vol. 7 ( 4 ) page： 620 - 629 2023.2

THIRD INTERIM ANALYSIS OF THE PHASE IV HEM-POWR STUDY EVALUATING THE REAL-WORLD EFFECTIVENESS OF DAMOCTOCOG ALFA PEGOL IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA A

Reding, MT; Roman, MTA; Sanabria, M; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

HAEMOPHILIA Vol. 29 page： 116 - 116 2023.2

INTERIM SUBGROUP ANALYSIS OF HEMOPHILIA A SEVERITY ON THE EFFECTIVENESS AND SAFETY OF DAMOCTOCOG ALFA PEGOL FROM THE REAL-WORLD OBSERVATIONAL HEM-POWR STUDY

Reding, M; Roman, MTA; Sanabria, M; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

AMERICAN JOURNAL OF HEMATOLOGY Vol. 98 page： E90 - E90 2023.2

The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients

Suzuki, N; Suzuki, N; Kawaguchi, Y; Okamoto, S; Kanematsu, T; Katsumi, A; Suzuki, A; Tamura, S; Kojima, T; Kiyoi, H; Matsushita, T

THROMBOSIS JOURNAL Vol. 21 ( 1 ) page： 10 2023.1

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs

Kashiwakura, Y; Baatartsogt, N; Yamazaki, S; Nagao, A; Amano, K; Suzuki, N; Matsushita, T; Sawada, A; Higasa, S; Yamasaki, N; Fujii, T; Ogura, T; Takedani, H; Taki, M; Matsumoto, T; Yamanouchi, J; Sakai, M; Nishikawa, M; Yatomi, Y; Yada, K; Nogami, K; Watano, R; Hiramoto, T; Hayakawa, M; Kamoshita, N; Kume, A; Mizukami, H; Ishikawa, S; Sakata, Y; Ohmori, T

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT Vol. 27 page： 404 - 414 2022.12

The Immunogenicity, Safety and Efficacy of N8-GP in Previously Untreated Patients (PUPs) with Severe Hemophilia A: pathfinder6 End-of-Trial Results

Kenet, G; Chuansumrit, A; Matsushita, T; Young, G; Yadav, V; Zak, M; Male, C

BLOOD Vol. 140 page： 2726 - 2727 2022.11

Efficacy and Safety of Personalized Prophylaxis with Simoctocog Alfa in Adult Japanese Previously Treated Patients with Severe Hemophilia a

Shima, M; Taki, M; Shirayama, R; Matsushita, T; Nishida, Y; Nagao, A; Ogawa, Y; Kawasugi, K

BLOOD Vol. 140 page： 11304 - 11305 2022.11

Fitusiran Prophylaxis Improves Health-Related Quality of Life in People with Hemophilia a or B, with or without Inhibitors: Results of ATLAS-PPX Study

Kenet, G; Nolan, B; Matsushita, T; Young, G; Quan, T; Cano, V; Sussebach, C; Andersson, S; Mei, BS; Afonso, M; Kavakli, K

BLOOD Vol. 140 page： 7977 - 7978 2022.11

Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol Prophylaxis in Previously Treated Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World Observational HEM-POWR Study

Reding, MT; Román, MTA; Sanabria, M; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

BLOOD Vol. 140 page： 5612 - 5614 2022.11

Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2)

Nogami, K; Taki, M; Matsushita, T; Kojima, T; Oka, T; Ohga, S; Kawakami, K; Sakai, M; Suzuki, T; Higasa, S; Horikoshi, Y; Shinozawa, K; Tamura, S; Yada, K; Imaizumi, M; Ohtsuka, Y; Iwasaki, F; Kobayashi, M; Takamatsu, J; Takedani, H; Nakadate, H; Matsuo, Y; Matsumoto, T; Fujii, T; Fukutake, K; Shirahata, A; Yoshioka, A; Shima, M

HAEMOPHILIA Vol. 28 ( 5 ) page： 745 - 759 2022.9

VWF-Gly2752Ser, a novel non-cysteine substitution variant in the CK domain, exhibits severe secretory impairment by hampering C-terminal dimer formation.

Okamoto S, Tamura S, Sanda N, Odaira K, Hayakawa Y, Mukaide M, Suzuki A, Kanematsu T, Hayakawa F, Katsumi A, Kiyoi H, Kojima T, Matsushita T, Suzuki N

Journal of thrombosis and haemostasis : JTH 2022.5

The change for qualitative balance of vascular endothelial growth factor-a may contribute to therapeutic efficacy for an anti-neutrophil cytoplasmic antibody associated vasculitis subtypes

Kikuchi, R; Naotake, T; Maruyama, S; Murohara, T; Matsushita, T

CLINICA CHIMICA ACTA Vol. 530 page： S205 - S206 2022.5

F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B.

Odaira K, Kawashima F, Tamura S, Suzuki N, Tokoro M, Hayakawa Y, Suzuki A, Kanematsu T, Okamoto S, Takagi A, Katsumi A, Matsushita T, Shima M, Nogami K, Kojima T, Hayakawa F

Thrombosis research Vol. 213 page： 91 - 96 2022.5

Medical Management of a Mural Thrombus Inducing Repeated Ischemic Strokes in a Patient with Congenital Afibrinogenemia.

Nishihori M, Araki Y, Suzuki N, Tamura S, Hattori M, Izumi T, Goto S, Yokoyama K, Uda K, Matsushita T, Saito R

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association Vol. 31 ( 7 ) page： 106526 2022.4

International consensus recommendations on the management of people with haemophilia B

Hart Daniel P., Matino Davide, Astermark Jan, Dolan Gerard, d'Oiron Roseline, Hermans Cedric, Jimenez-Yuste Victor, Linares Adriana, Matsushita Tadashi, McRae Simon, Ozelo Margareth C., Platton Sean, Stafford Darrel, Sidonio Robert F. Jr., Tiede Andreas

THERAPEUTIC ADVANCES IN HEMATOLOGY Vol. 13 page： 20406207221085202 2022.4

Indoxyl Sulfate Activates NLRP3 Inflammasome to Induce Cardiac Contractile Dysfunction Accompanied by Myocardial Fibrosis and Hypertrophy

Yamaguchi Kazutoshi, Yisireyili Maimaiti, Goto Sumie, Cheng Xian Wu, Nakayama Takayuki, Matsushita Tadashi, Niwa Toshimitsu, Murohara Toyoaki, Takeshita Kyosuke

CARDIOVASCULAR TOXICOLOGY Vol. 22 ( 4 ) page： 365 - 377 2022.4

Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors.

Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupancic-Salek S, Oldenburg J, Chowdary P

Blood advances 2022.3

Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development.

Tamura S, Mukaide M, Katsuragi Y, Fujii W, Odaira K, Suzuki N, Tsukiji N, Okamoto S, Suzuki A, Kanematsu T, Katsumi A, Takagi A, Ikeda K, Ueyama J, Hirayama M, Suzuki-Inoue K, Matsushita T, Kojima T, Hayakawa F

The Journal of biological chemistry Vol. 298 ( 5 ) page： 101833 2022.3

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic

Al-Riyami Arwa Z., Burnouf Thierry, Wood Erica M., Devine Dana V., Oreh Adaeze, Apelseth Torunn Oveland, Goel Ruchikha, Bloch Evan M., van den Berg Karin, Getshen Mahrukh, Louw Vernon, Ang Ai Leen, Lee Cheuk Kwong, Rahimi-Levene Naomi, Stramer Susan L., Vassallo Ralph, Schulze Torsten J., Patidar Gopal Kumar, Pandey Hem Chandra, Dubey Rounak, Badawi Maha, Hindawi Salwa, Meshi Abdullah, Matsushita Tadashi, Sorrentino Enrico, Grubovic Rastvorceva Rada M., Bazin Renee, Vermeulen Marion, Nahirniak Susan, Tsang Hamilton C., Vrielink Hans, Triyono Teguh, Addas-Carvalho Marcelo, Hecimovic Ana, Torres Oscar W., Mutindu Samclide M., Bengtsson Jesper, Dominguez Diego, Sayedahmed Ahmed, Hanisa Musa Rozi, Gautam Bipul, Herczenik Eszter, So-Osman Cynthia

VOX SANGUINIS 2022.3

AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors

Matsushita Tadashi, Suzuki Nobuaki, Nagao Azusa, Nagae Chiai, Yamaguchi-Suita Haruko, Kyogoku Yui, Ioka Akiko, Nogami Keiji

BMJ OPEN Vol. 12 ( 3 ) page： e057018 2022.3

　 PREV - NEXT 　

<MATSUSHITA, Tadashi>

Papers - MATSUSHITA, Tadashi